CIBC Private Wealth Group, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 216 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC Private Wealth Group, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,493
-99.6%
26,239
+20.8%
0.00%
-100.0%
Q3 2019$337,000
-9.7%
21,7230.0%0.00%0.0%
Q2 2019$373,000
-17.1%
21,723
-22.2%
0.00%
-50.0%
Q1 2019$450,000
-4.5%
27,935
-13.2%
0.00%0.0%
Q4 2018$471,000
-14.2%
32,173
+6.4%
0.00%0.0%
Q3 2018$549,000
+26.2%
30,232
+17.3%
0.00%0.0%
Q2 2018$435,0000.0%25,766
+15.9%
0.00%0.0%
Q1 2018$435,000
-5.8%
22,225
-2.5%
0.00%0.0%
Q4 2017$462,000
+3.4%
22,801
-11.3%
0.00%0.0%
Q3 2017$447,000
+31.1%
25,718
-3.4%
0.00%0.0%
Q2 2017$341,000
+5.2%
26,625
+6.5%
0.00%0.0%
Q1 2017$324,000
+31.2%
25,0100.0%0.00%0.0%
Q4 2016$247,000
-1.2%
25,010
+20.8%
0.00%0.0%
Q3 2016$250,000
-19.9%
20,700
+15.1%
0.00%0.0%
Q4 2015$312,000
+39.3%
17,985
+7.6%
0.00%0.0%
Q3 2015$224,000
-51.9%
16,715
-19.0%
0.00%
-33.3%
Q2 2015$466,000
+73.9%
20,625
+9.9%
0.00%
+50.0%
Q1 2015$268,00018,7700.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders